Healthcare -
Biotechnology - NASDAQ - US
$ 40.61
0.794 %
$ 2.63 B
Market Cap
-17.35
P/E
Price Target
Average
37.59%
Revenue Forecast
Estimate
32.29%
EBIT
Estimate
--3.20%
Net Income
Estimate
--4.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Kymera Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for KYMR of $55.9 , with forecasts ranging from
a
low of
$46 to a high of $65 .
KYMR Lowest Price Target
Wall Street Target
46 USD
13.27%
KYMR Average Price Target
Wall Street Target
55.9 USD
37.59%
KYMR Highest Price Target
Wall Street Target
65 USD
60.06%
REVENUE FORECAST
Revenue Forecast Chart KYMR
EBIT FORECAST
EBIT Forecast Chart KYMR
NET INCOME FORECAST
Net Income Chart KYMR